Endo Health to acquire Paladin Labs for $1.6B Endo Health Solutions (ENDP) has agreed to acquire Canadian peer Paladin Labs (PLDLF) for about $1.6B in a cash and stock deal that will expand Endo's presence in emerging markets as well as in Canada.Endo will pay C$77 ($73.98) a share, representing a premium of over 20% to Paladin's close yesterday.Endo expects the deal to be immediately accretive to its 2014 adjusted EPS
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.